ALL RANGEKIT
LIVE

Serial Number

99106106

Owner

Open Healthcare, Inc.

Attorney

James R Menker

Filing Date

Mar 26, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ALL RANGEKIT Trademark

Serial Number: 99106106

ALL RANGEKIT is a trademark filed by Open Healthcare, Inc. on March 26, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Open Healthcare, Inc. (9 trademarks)

280, Cheonho-daero
Seongdong-gu, Seoul 04804 , KR

Entity Type: 03

Trademark Details

Filing Date

March 26, 2025

Registration Date

Not Registered

Published for Opposition

November 11, 2025

Goods & Services

Medical fluid injectors; Computerized medical recording and analysis apparatus for the diagnosis and treatment of arrhythmias; Medical instruments for use in performing biopsies; Medical diagnostic apparatus for testing for viruses; Medical diagnostic apparatus for detecting infectious diseases; Medical test kits for diabetes monitoring for home use; Medical apparatus and instruments, namely, self testing kits comprised of blood collection needles and blood collection tubes, and diagnostic apparatus for medical purposes used in medical laboratories for testing blood sugar levels, Human immunodeficiency virus (HIV), Hepatitis B virus (HBV), Hepatitis C virus (HCV), Syphilis, and Herpes simplex virus (HSV); Medical apparatus and instruments, namely, self testing kits comprised of urine collection containers, and diagnostic apparatus for detecting sexually transmitted diseases, namely, human papillomavirus (HPV), Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis, Trichomonas vaginalis, Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2), Treponema pallidum, Gardnerella vaginalis, Candida albicans; Medical apparatus and instruments, namely, self testing kits comprised of stool collection containers and diagnostic apparatus for medical purposes used in medical laboratories for detecting gastrointestinal infections and colorectal cancer; Medical apparatus and instruments, namely, self-testing kits comprised of saliva collection swabs and saliva collection tubes and diagnostic apparatus for medical purposes used in medical laboratories for testing hormone levels and detecting viral infections; Medical apparatus and instruments, namely, self testing kits comprised of nasal swabs and nasal swab sample collection tubes and diagnostic apparatus for medical purposes used in medical laboratories for detecting respiratory infections; Medical apparatus and instruments, namely, self testing kits comprised of oral swabs and oral swab sample collection containers and diagnostic apparatus for medical purposes used in medical laboratories for detecting oral infections; Medical apparatus and instruments for detecting infectious diseases, metabolic disorders, and genetic conditions; Medical apparatus and instruments for self-collected sample testing and laboratory analysis; Medical diagnostic kits consisting primarily of medical diagnostic apparatus for testing for viruses, bacteria, fungus, parasite and also including reagents; Medical diagnostic apparatus for use in analyzing and measuring electrolytes in the body; Medical diagnostic apparatus for use in analyzing urine samples for detecting human papillomavirus (HPV) and other sexually transmitted infections (STIs); Medical diagnostic apparatus for use in analyzing and measuring components in urine, namely, proteins, ketones, and glucose; Medical diagnostic apparatus for use in analyzing and measuring hormone levels and metabolic markers in the body; in vitro diagnostic devices in the nature of medical diagnostic instruments for the analysis of urine samples, stool samples, saliva samples, nasal swab samples, oral swab samples, vaginal swab samples, cervical swab samples, sputum samples, and blood samples; medical test kits for chronic disease monitoring, namely, diabetes monitoring, metabolic disorders monitoring, and cardiovascular health monitoring for home use

Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of respiratory infections, gastrointestinal infections, and sexually transmitted infections (STIs); Pharmaceutical preparations for the treatment of metabolic disorders, diabetes, hypertension, and hyperlipidemia antiviral and antimicrobial; Pharmaceutical preparations for the treatment of viral and bacterial infections, namely, human papillomavirus (HPV) and sexually transmitted infections (STIs); Pharmaceutical preparations for the treatment of neurological and mental health disorders, depression, anxiety, and sleep disorders; Medical diagnostic reagents; In vitro diagnostic preparations for medical purposes; Diagnostic preparations for in vitro testing for medical use; Antivirals; Medicines for dental purposes; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medicated skin care preparations; Pharmaceutical preparations for skin care; Diagnostic preparations for medical and veterinary use; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, neurological disorders, muscle dystonia, skin disorders and infections; Dietary supplements; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of alcohol, nicotine, toxins, infectious diseases, metabolic disorders, and genetic conditions; Reagents for medical use; Diagnostic test reagents for medical use; Reagents for use in diagnostic tests for medical use; Reagents for use in medical genetic testing; Reagents and media for medical and veterinary diagnostic purposes; Specimen collection kits comprised primarily of swabs for medical purposes and also including plastic bags for transmitting medical specimens; Health food supplements; Diagnostic preparations for medical purposes used by medical laboratories

Hospital services; Health screening services in the field of asthma; Health screening services in the field of sleep apnea; Health screening services in the field of cancer; Health screening services in the field of neurological disorders; Health screening services in the field of muscle dystonia; Health screening services in the field of skin disorders; Health screening services in the field of infections; Performing diagnosis of diseases; Telemedicine services; Medical testing for diagnostic or treatment purposes; Medical screening; Medical information; Medical examination; Health center services; Providing health information via a website; Providing medical information via a website; Health assessment services; Consulting services in the field of health; Medical diagnostic services; Medical testing services

Filing History

CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 3, 2026 AITU
TEAS STATEMENT OF USE RECEIVED
Feb 11, 2026 EISU
TEAS REQUEST TO DIVIDE RECEIVED
Feb 11, 2026 ERTD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 6, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 14, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 14, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 14, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 14, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 14, 2025 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 8, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 8, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 8, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 28, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 28, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 28, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 26, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 11, 2025 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 26, 2025 MAFR
NEW APPLICATION ENTERED
Mar 26, 2025 NWAP